BENCHMARKS AND PERFORMANCE. Licensee agrees to the following Benchmarks for its performance under this Agreement and, within thirty (30) days of achieving a Benchmark, shall notify PHS that the Benchmark has been achieved. Regulatory Benchmarks for the Prime Indications
BENCHMARKS AND PERFORMANCE. Licensee agrees to the following Benchmarks for its performance under this Agreement and, within [***] of achieving a Benchmark, shall notify PHS that the Benchmark has been achieved.
BENCHMARKS AND PERFORMANCE. Licensee agrees to the following Benchmarks for its performance under this Agreement and, within ten (10) days of achieving a Benchmark, shall notify PHS that the Benchmark has been achieved. Not Done
BENCHMARKS AND PERFORMANCE. The Licensee agrees to the following Benchmarks for its performance under this Agreement and, within thirty (30) days of achieving a Benchmark, shall notify the NIH that the Benchmark has been achieved. Benchmark Deadline
BENCHMARKS AND PERFORMANCE. Now therefore, PHS and Licensee, intending to be bound, hereby mutually agree to the following:
BENCHMARKS AND PERFORMANCE. The Licensee agrees to the following Benchmarks for its performance under this Agreement and, within thirty (30) days of achieving a Benchmark, shall notify the NIAID that the Benchmark has been achieved. Benchmarks for elderly RSV vaccination indication
BENCHMARKS AND PERFORMANCE. [***] [***] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. APPENDIX E—COMMERCIAL DEVELOPMENT PLAN [***] [***] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. APPENDIX F—EXAMPLE ROYALTY REPORT [***] [***] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. APPENDIX G—ROYALTY PAYMENT OPTIONS [***] [***] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
BENCHMARKS AND PERFORMANCE. Licensee agrees to the following Benchmarks for its performance under this Agreement and, within thirty (30) days of achieving a Benchmark, shall notify PHS that the Benchmark has been achieved. Regulatory Benchmarks for the Prime Indications For the Anti-cancer therapeutic indication (for C1-IB-MECA):
BENCHMARKS AND PERFORMANCE g. The following Paragraph 6.13 shall be added to the Agreement:
BENCHMARKS AND PERFORMANCE. LICENSEE agrees to the following BENCHMARKS for the purpose of measuring its performance under this AGREEMENT. LICENSEE shall notify PHS in writing within thirty (30) days of achieving all such BENCHMARKS. They are:
